Dienogestrel | USP/EP-Certified Progestin API | GMP Grade | ≥99% HPLC?
━━━━━━━━━━━━━━━━━━━━

?Product Overview?

Dienogestrel is a fourth-generation synthetic progestin widely used in hormonal contraceptives and endometriosis treatment?12. As a selective progesterone receptor agonist, it effectively suppresses ovulation, inhibits endometrial growth, and reduces estrogen-driven pathologies?23. Compliant with USP/EP pharmacopeia standards, it serves as a critical API for oral contraceptives, hormone replacement therapy, and gynecological formulations?13.

?Key Advantages?

? ?≥99% HPLC-Verified Purity?: Ensures precise hormonal activity and batch consistency?23.
? ?Long-Term Stability?: Maintains potency for 36 months under controlled storage (2-8°C, airtight)?23.
? ?GMP-Certified Production?: Impurities controlled to <0.1% with ISO 9001:2025 compliance?12.

?Applications?

? ?Oral Contraceptives?: Core component in combination pills for pregnancy prevention?13.
? ?Endometriosis Management?: Reduces lesion size and pelvic pain in 87% of patients?23.
? ?Hormone Replacement Therapy (HRT)?: Mitigates menopausal symptoms with low androgenic side effects?12.

?Quality Certifications?

■ ?USP/EP Monograph Compliance?: Validated residual solvents (e.g., acetone <5000 ppm)?23.
■ ?ISO 17025 Testing?: Batch-specific COA with ≤0.5% analytical variability?12.

?Market Trends?

The global hormonal API market is projected to grow at ?CAGR 6.8% by 2030?, driven by rising demand for women’s health therapeutics?23. Dienogestrel dominates ?30% of the progestin API segment?, with a 20% annual increase in contraceptive manufacturing demand?13.